miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

Platinum drugs are used in first-line to treat ovarian cancer, but the most of patients eventually develop resistance to these drugs. Although both c-Myc and EZH2 have been implicated in the regulation of cisplatin resistance in ovarian cancer, the interplay between these two regulators is poorly un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Sun, Jin, Cai, Xin, Yung, Mingo MH, Zhou, Wei, Li, Jing, Zhang, Yi, Li, Zhuqing, Liu, Stephanie S, Cheung, Annie NY, Ngan, Hextan YS, Li, Yiliang, Dai, Zhijun, Kai, Yan, Tzatsos, Alexandros, Peng, Weiqun, Chan, David W., Zhu, Wenge
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7474467/
https://ncbi.nlm.nih.gov/pubmed/30166592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0459-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados